CGP additionally resulted in genetic counseling consultation for three patients: one patient with CLL who was found to have a BRCA2 mutation, one patient with CLL who was found to have an MSH6 mutation, and one patient with marginal zone lymphoma who was found to have a VHL mutation. This evidence concerns the gene BRCA2 and marginal zone lymphoma.